STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 79 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,159,000 | -6.7% | 4,489,687 | +35.8% | 4.17% | -18.8% |
| Q2 2021 | $9,818,000 | +698.2% | 3,305,617 | +641.7% | 5.13% | +673.2% |
| Q1 2021 | $1,230,000 | -62.5% | 445,701 | -67.0% | 0.66% | -73.6% |
| Q4 2020 | $3,281,000 | -18.8% | 1,350,000 | -29.9% | 2.51% | -40.3% |
| Q3 2020 | $4,042,000 | +347.6% | 1,924,956 | +345.7% | 4.20% | +568.5% |
| Q4 2019 | $903,000 | +77.8% | 431,853 | +166.2% | 0.63% | +79.7% |
| Q2 2019 | $508,000 | -45.5% | 162,244 | -13.3% | 0.35% | -34.7% |
| Q1 2019 | $932,000 | -62.7% | 187,074 | -45.7% | 0.54% | -64.2% |
| Q4 2017 | $2,496,000 | – | 344,282 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,083,442 | $22,310,000 | 14.49% |
| AIGH Capital Management LLC | 2,194,173 | $6,056,000 | 1.27% |
| Worth Venture Partners, LLC | 550,196 | $1,519,000 | 0.74% |
| Stonepine Capital Management, LLC | 445,701 | $1,230,000 | 0.66% |
| NEA Management Company, LLC | 4,141,308 | $11,430,000 | 0.26% |
| Ikarian Capital, LLC | 1,160,450 | $3,203,000 | 0.11% |
| ALGERT GLOBAL LLC | 99,397 | $274,000 | 0.09% |
| Zebra Capital Management LLC | 24,039 | $66,000 | 0.07% |
| HighVista Strategies LLC | 28,432 | $79,000 | 0.06% |
| Orbimed Advisors | 1,744,669 | $4,815,000 | 0.04% |